Advantest Earns Best Supplier Award From STATS ChipPAC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Advantest Earns Best Supplier Award From STATS ChipPAC

TOKYO--(Marketwired - Jul 31, 2013) - Semiconductor test equipment leader Advantest Corporation ( TSE : 6857 ) ( NYSE : ATE ) has received the Best Supplier Award from Singapore-based STATS ChipPAC Ltd. (SGX-ST: STATSChP), a leading provider of advanced semiconductor packaging and test services. Advantest won this year's award by unanimous decision of the judges and now has earned this supplier recognition every year since 2007.

"In 2012, STATS ChipPAC continued to strengthen our leadership position in advanced packaging technologies, which has enabled us to gain significant traction in a number of key programs with market leaders in the mobile space," said Wan Choong Hoe, executive vice president and chief operating officer, STATS ChipPAC. "It is our pleasure to recognize Advantest's achievements and we appreciate their ability to consistently deliver quality and responsive services that help us deliver on our commitments to our customers."

The Best Supplier Award is STATS ChipPAC's highest honor recognizing material and equipment suppliers for distinguished service and performance. The award is judged on how well a supplier performs in terms of quality, on-time delivery, technology, service, responsiveness and cost competitiveness.

Advantest earned the award on the strength of its fast turnaround time and services, which include fast response to short lead-times, demand upsides and schedule changes. In presenting the award, STATS ChipPAC also expressed its appreciation of Advantest's field service support team for keeping its installed testers running at optimal production conditions.

"This award exemplifies our company-wide dedication to helping our customers succeed by delivering the industry's best service, support and product quality," said Haruo Matsuno, president and chief executive officer of Advantest Corporation.

This award from STATS ChipPAC is the latest industry honor earned by Advantest this year. The company also ranked among the 10 BEST Suppliers of semiconductor production equipment for 2013 in an industry survey conducted by VLSIresearch and received Texas Instruments' 2012 Supplier Excellence Award in April. In May, Advantest's president and CEO, Haruo Matsuno, received the ACE (Annual Creativity in Electronics) Award for Executive of the Year from semiconductor industry journals EE Times and EDN .

About Advantest Corporation A world-class technology company, Advantest is the leading producer of automatic test equipment (ATE) for the semiconductor industry and a premier manufacturer of measuring instruments used in the design and production of electronic instruments and systems. Its leading-edge systems and products are integrated into the most advanced semiconductor production lines in the world. The company also focuses on R&D for emerging markets that benefit from advancements in nanotech and terahertz technologies, and has introduced multi-vision metrology scanning electron microscopes essential to photomask manufacturing, as well as a groundbreaking 3D imaging and analysis tool. Founded in Tokyo in 1954, Advantest established its first subsidiary in 1982, in the USA, and now has subsidiaries worldwide. More information is available at www.advantest.com .

COMPANY CONTACT: Judy Davies VP of Global Marketing Communications +1 408-456-3717 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles